<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03106844</url>
  </required_header>
  <id_info>
    <org_study_id>2017P000386</org_study_id>
    <nct_id>NCT03106844</nct_id>
  </id_info>
  <brief_title>The ICON Study: Outcomes After FMT for Patients With IBD and CDI</brief_title>
  <official_title>The ICON Study: Inflammatory Bowel Disease and Recurrent Clostridium Difficile Infection: Outcomes After Fecal Microbiota Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Miriam Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators will evaluate patients with IBD and and at least 2 confirmed
      c.difficile infections who will be undergoing FMT. The investigators will assess patients
      before FMT and then follow patients prospectively post FMT at week 1, 8 and 12 to assess for
      recurrence of c.difficile infection and IBD outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>FMT Failure</measure>
    <time_frame>8 weeks</time_frame>
    <description>Recurrence of c.diffile infection</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Inflammatory Bowel Diseases</condition>
  <condition>Clostridium Difficile Infection</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All patients in this study will receive Fecal Microbiota Tranplantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fecal Microbiota Transplantation</intervention_name>
    <description>Patients with at least 2 episodes of CDI and IBD will undergo a single FMT</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>FMT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults age 18 or greater

          -  Confirmed recurrent CDI by positive PCR or EIA toxin test defined at ≥ 2 episodes and
             vancomycin failure within one year with the most recent being within the past 3
             months.

          -  Confirmed diagnosis of IBD with colonic involvement (ulcerative colitis, Crohn's
             colitis or ileocolitis or indeterminate colitis) for ≥ 3 months

          -  Undergoing FMT via colonoscopy for CDI as part of standard medical care

        Exclusion Criteria:

          -  Unable or unwilling to undergo a colonoscopy

          -  Inpatient status

          -  Anticipated immediate or upcoming surgery within 30 days

          -  Need for continued non-anti-CDI antibiotic therapy

          -  History of total or subtotal proctocolectomy

          -  Isolated ileal or small bowel disease

          -  Pregnancy or lactation

          -  Female patients who are pregnant or breastfeeding or plan to become pregnant in the
             next 6 months.

          -  Patients who are unable to give informed consent

          -  Participation in a clinical trial in the preceding 30 days or simultaneously during
             this trial

          -  Severe food allergy (anaphylaxis or anaphylactoid-like reaction)

          -  Life expectancy &lt; 6 months

          -  Unable to adhere to protocol requirements

          -  Any condition that the physician investigators deems unsafe, including other
             conditions or medications that the investigator determines that it will put the
             subject at greater risk from FMT

          -  Known concurrent HIV, Hepatitis B or C infection

          -  Concurrent PSC

          -  Patients with WBC&lt; 3.0 x109th/L at baseline

          -  Patients with platelet count &lt; 100 x109th/L

          -  Patients with initial elevation of AST or ALT &gt; 1.5 times above normal limit at
             baseline

          -  Non - steroidal anti-inflammatory medications (NSAIDs) as long-term treatment, defined
             as use for at least 4 days a week each month

          -  Treatment with vancomycin or metronidazole for more then 60 days prior to enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jessica R Allegretti, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jessica R Allegretti, MD,MPH</last_name>
    <phone>617-732-6389</phone>
    <email>jallegretti@partners.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Madeline Carrellas</last_name>
    <email>mcarrellas@partners.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Allegretti, MD, MPH</last_name>
      <phone>617-732-6389</phone>
      <email>jallegretti@partners.org</email>
    </contact>
    <contact_backup>
      <last_name>Madeline Carrellas</last_name>
      <phone>617-732-9223</phone>
      <email>mcarrellas@partners.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2017</study_first_submitted>
  <study_first_submitted_qc>April 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2017</study_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Jessica Ravikoff Allegretti</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>FMT</keyword>
  <keyword>IBD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

